sales@jinjingroup.com

  News Introduction

Vinpocetine(CAS 42971-09-5) injection on the acute onset of pulmonary heart disease has a good clinical effect

Date : 2016/10/8 11:21:47

Recently, Xin'an County, Henan Province, the Second People's Hospital researchers published papers to explore the vinpocetine(CAS 42971-09-5) injection in the treatment of chronic pulmonary heart disease in acute exacerbation of clinical efficacy. Studies have shown that vinpocetine injection on the acute onset of pulmonary heart disease has a good clinical efficacy, worthy of clinical use. The article published in 2014 thirty-first issue of "Chinese community physicians" magazine.

88 patients with acute episodes of chronic pulmonary heart disease were randomly divided into control group (n = 43) and treatment group (n = 45). The patients in the control group were treated with routine treatment and the treatment group was treated with vinpocetine(CAS 42971-09-5) injection. Both groups were treated for 14 days, observation of the two groups of efficacy, arterial blood gas analysis, hemorheology.

Vinpocetine(CAS 42971-09-5) injection on the acute onset of pulmonary heart disease has a good clinical effect, can improve the acute stage of pulmonary heart disease hypercoagulable, high viscosity state.